Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial

American Heart Journal

Volumn 157, Issue 4, 2009, Pages

  Truong, Quynh A ^a   Cannon, Christopher P ^b   Zakai, Neil A ^c   Rogers, Ian S ^a   Giugliano, Robert P ^b   Wiviott, Stephen D ^b   McCabe, Carolyn H ^b   Morrow, David A ^b   Braunwald, Eugene ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; EVALUATION; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART FAILURE; HEART INDEX; HEART INFARCTION; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; SECONDARY ANALYSIS; ST SEGMENT ELEVATION; THROMBOLYSIS IN MYOCARDIAL INFARCTION RISK INDEX;

EID: 62949203709     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.12.010     Document Type: Article

References (19)

1. Morrow D.A., Antman E.M., Giugliano R.P., et al. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy. Lancet 358 (2001) 1571-1575
2. Wiviott S.D., Morrow D.A., Frederick P.D., et al. Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction. J Am Coll Cardiol 44 (2004) 783-789
3. Ilkhanoff L., O'Donnell C.J., Camargo C.A., et al. Usefulness of the TIMI Risk Index in predicting short- and long-term mortality in patients with acute coronary syndromes. Am J Cardiol 96 (2005) 773-777
4. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. The TIMI Study Group. N Engl J Med 320 (1989) 618-627
5. Williams D.O., Braunwald E., Knatterud G., et al. One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial. Circulation 85 (1992) 533-542
6. Terrin M.L., Williams D.O., Kleiman N.S., et al. Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial. J Am Coll Cardiol 22 (1993) 1763-1772
7. Morrow D.A., Antman E.M., Charlesworth A., et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102 (2000) 2031-2037
8. Harrell Jr. F.E., Califf R.M., Pryor D.B., et al. Evaluating the yield of medical tests. JAMA 247 (1982) 2543-2546
9. Morrow D.A., Antman E.M., Parsons L., et al. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA 286 (2001) 1356-1359
10. Granger C.B., Goldberg R.J., Dabbous O., et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 163 (2003) 2345-2353
11. Eagle K.A., Lim M.J., Dabbous O.H., et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 291 (2004) 2727-2733
12. Chang W.C., Kaul P., Fu Y., et al. Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction. Eur Heart J 27 (2006) 419-426
13. Bradshaw P.J., Ko D.T., Newman A.M., et al. Validation of the Thrombolysis In Myocardial Infarction (TIMI) risk index for predicting early mortality in a population-based cohort of STEMI and non-STEMI patients. Can J Cardiol 23 (2007) 51-56
14. Wiviott S.D., Morrow D.A., Frederick P.D., et al. Application of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction. J Am Coll Cardiol 47 (2006) 1553-1558
15. Jourdain P., Jondeau G., Funck F., et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 49 (2007) 1733-1739
16. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
17. Khush K.K., Waters D.D., Bittner V., et al. Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study. Circulation 115 (2007) 576-583
18. Scirica B.M., Morrow D.A., Cannon C.P., et al. Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study. J Am Coll Cardiol 47 (2006) 2326-2331
19. Cantor W. Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI). SCAI-ACC i2 Summit/American College of Cardiology Annual Scientific Session; Chicago, IL (2008)